title: A double-blind study of the influences of eszopiclone on dysgeusia and taste function.
abstract: Taste disturbance is a common, but poorly understood, side effect of a large number of medications. This double-blind study examined the frequency, intensity, and quality of taste disturbances related to the widely used hypnotic sleep aid eszopiclone (ESZ; Lunesta, as well as their associations with age, sex, body mass index (BMI), time of day, phenyl thiocarbamide (PTC) taste sensitivity, and ESZ saliva and blood levels. Sixty six percent of 24 female subjects and 53% of 15 male subjects reported dysgeusic sensations, mostly bitter/metallic, during the drug administration (respective placebo figures 17% and 7%). No meaningful relationships were found between the frequency or the intensity of the sensations and age, BMI, or PTC taste sensitivity. Dysgeusia was more intense and longer lasting in women than in men, stronger in the morning than in the evening, and positively correlated with drug plasma and saliva levels. In women, intensity ratings decreased across treatment days. Taste test measures were marginally, at best, influenced by ESZ. This study demonstrates, for the first time, that the dysgeusia associated with ESZ is systemically influenced by a number of factors, including sex, time since drug administration, and both blood and saliva levels of the drug.
authors.affiliation: Smell and Taste Center, University of Pennsylvania Medical Center, 5 Ravdin Building, 3400 Spruce Street, Philadelphia, PA 19104, USA. doty@mail.med.upenn.edu
authors.forename: Richard L
authors.initials: RL
authors.lastname: Doty
authors.forename: Jonathan
authors.initials: J
authors.lastname: Treem
authors.forename: Isabelle
authors.initials: I
authors.lastname: Tourbier
authors.forename: Natasha
authors.initials: N
authors.lastname: Mirza
mesh_terms: D000328:Adult; D053961:Azabicyclo Compounds / Q000009:adverse effects* / Q000097:blood / Q000494:pharmacology; D004311:Double-Blind Method; D004408:Dysgeusia / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology*; D000069582:Eszopiclone; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000097:blood / Q000494:pharmacology; D012737:Sex Factors; D013649:Taste / Q000187:drug effects* / Q000502:physiology*; D013997:Time Factors; D055815:Young Adult
chemical_list: D053961:Azabicyclo Compounds; D010879:Piperazines; D000069582:Eszopiclone